IFLR1000

Lonza Group SFr2.25 billion rights issue

12/5/2017
Rights issue
Select tab

SFr 2.25 billion

$ 2.31 billion

Completed

12/5/2017

Overview:

  • The Lonza Group has undertaken a SFr2.25 billion rights issue.
  • Proceeds will be used for the acquisition of Capsugel. 
  • The underwriters on the deal were UBS and BofA Merrill Lynch, who have acted as joint bookrunners and joint global coordinators.
  • Citigroup, Credit Suisse, Goldman Sachs and JP Morgan have acted as joint bookrunners. 

Katrin Kostadinova - Data analyst 

Jurisdiction:

Switzerland

Deal type:

Rights issue

Practice area:

Capital markets : Equity

Governing law:

Switzerland

Industry sector:

Healthcare

Firm:
Bär & Karrer

Party: Lonza Group (Issuer)

Related deals